Effect of TanshinoneIIA on MAPK signaling pathway in cardiomyocytes hypertrophy induced by AngII
Qiansheng Liang
Abstract
Qiansheng Liang
Abstract
Objective To observe effects of Sodium tanshinoneⅡA sulfonate(STS)on angiotensionⅡ(AngⅡ)-induced cardiomyocyte hypertrophy and the expression of phosphorylated mitogen-activated protein kinase(p-MAPK).Methods In the primary culture of neonatal rat cardiomyocytes,as indexes of cardiomyocyte hypertrophy,the total protein was determined by coomassie brilliant blue and protein synthesis rate was measured by[~3H]-Leucine incorporation.The expression of p-MAPK was assessed u- sing Western blot.Results①The total protein and protein synthesis rate stimulated by AngⅡ(1μmol/L)in the cardiomyocytes in- creased significantly in contrast to control;STS can effectively decrease the increased total protein level induced by AngⅡand marked- ly inhibited syntheses of protein.②Pretreatment of cardiomyocyte with AngⅡ(1μmol/L)for 5 rain,the p-MAPK(p44MAPK/ p42MAPK)protein expression began to increase,the peak effect was at 10 rain.While pretreatment with STS(2,10,50μmol/L), AngⅡ-induced increase in p-MAPK were inhibited evidently.③Pretreatment cardiomyocyte with STS in different dose for 30min, we find STS can inhibit the expression of p-MAPK stimulated by AngⅡin a dose-dependent manner.Conclusion The results sug- gest that activation of MAPK may play an important role in cardiomyocytes hypertrophy induced by AngⅡ,and the anti-hypertrophic effect of STS on cardiomyocyte hypertrophy induced by AngⅡmay be associated to it's effect of inhibition to MAPK signaling pathway.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe effects of Sodium tanshinoneⅡA sulfonate(STS)on angiotensionⅡ(AngⅡ)-induced cardiomyocyte hypertrophy and the expression of phosphorylated mitogen-activated protein kinase(p-MAPK).Methods In the primary culture of neonatal rat cardiomyocytes,as indexes of cardiomyocyte hypertrophy,the total protein was determined by coomassie brilliant blue and protein synthesis rate was measured by[~3H]-Leucine incorporation.The expression of p-MAPK was assessed u- sing Western blot.Results①The total protein and protein synthesis rate stimulated by AngⅡ(1μmol/L)in the cardiomyocytes in- creased significantly in contrast to control;STS can effectively decrease the increased total protein level induced by AngⅡand marked- ly inhibited syntheses of protein.②Pretreatment of cardiomyocyte with AngⅡ(1μmol/L)for 5 rain,the p-MAPK(p44MAPK/ p42MAPK)protein expression began to increase,the peak effect was at 10 rain.While pretreatment with STS(2,10,50μmol/L), AngⅡ-induced increase in p-MAPK were inhibited evidently.③Pretreatment cardiomyocyte with STS in different dose for 30min, we find STS can inhibit the expression of p-MAPK stimulated by AngⅡin a dose-dependent manner.Conclusion The results sug- gest that activation of MAPK may play an important role in cardiomyocytes hypertrophy induced by AngⅡ,and the anti-hypertrophic effect of STS on cardiomyocyte hypertrophy induced by AngⅡmay be associated to it's effect of inhibition to MAPK signaling pathway.
Key concepts: MAPK/ERK pathway, Muscle hypertrophy, Internal medicine, Endocrinology, Western blot, Medicine, Protein kinase A, Kinase